Citations

Showing 10 of 107863 citations.

P4–289: Mechanistic insights into the in vitro and in vivo modulation of Aβ42 levels and amyloid pathology by NSAIDS and related compounds
Kukar, Thomas , Ladd, Thomas B., Kache, Rajashaker, Fauq, Abdul H. , Koo, Edward H. , Golde, Todd E. , Bann, Maralyssa , Fraering, Patrick C. , Wolfe, Michael S.

Mayo Clinic

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_20 | Pages: No page available

10.1016/j.jalz.2006.05.2028 Get It

P4–258: Heterologous amyloid vaccines induce a generic anti–amyloid response
Das, Pritam , Hrncic, Rudi, Golde, Todd E.

Mayo Clinic

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_19 | Pages: No page available

10.1016/j.jalz.2006.05.1997 Get It

P4–251: Decreased plasma beta amyloid levels in Alzheimer patients treated chronically with Intravenous immunoglobulin (IVIG)
Relkin, Norman , Younkin, Linda H., Younkin, Steven G. , Monthé, Carmen, Adamiak, Basia, Szabo, Paul, Schiff, Richard I., Weksler, Marc E.

Mayo Clinic

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_19 | Pages: No page available

10.1016/j.jalz.2006.05.1990 Get It

P4–196: The capacity of persons with very mild to moderate AD to provide informed consent to enroll in a clinical trial
Karlawish, Jason , vanDyck, Christopher, Marson, Daniel , Kim, Scott Y. H. , Knopman, David S. , James, Bryan D.

Mayo Clinic

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_19 | Pages: No page available

10.1016/j.jalz.2006.05.1935 Get It

P4–187: Compensating for memory loss in amnestic mild cognitive impairment
Greenaway, Melanie C., Lepore, Sue, Lunde, Angela , Hanna, Sherrie , Smith, Glenn E. , Boeve, Bradley F.

Mayo Clinic

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_19 | Pages: No page available

10.1016/j.jalz.2006.05.1926 Get It

P4–185: Patient survey of comprehensive dementia evaluation
Parfitt, Francine, Fletcher, Rita, Graff‐Radford, Neill R., Johnson, Heather K.

Mayo Clinic

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_18 | Pages: No page available

10.1016/j.jalz.2006.05.1924 Get It

S1–04–06: Alzheimer's disease with amygdala Lewy bodies: A distinct form of Lewy body disease
Uchikado, Hirotake, Dickson, Dennis W.

Mayo Clinic

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_1 | Pages: No page available

10.1016/j.jalz.2006.05.032 Get It

P2–136: Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE ϵ4 allele, in relation to cognitive function and cerebral glucose metabolism
Brimijoin, S, Kadir, Ahmadul, Darreh‐Shori, Taher , Almkvist, Ove , Nordberg, Agneta

Mayo Clinic

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_9 | Pages: No page available

10.1016/j.jalz.2006.05.974 Get It

P2–058: Pharmacological analysis of cellular models of PHF–type tau hyperphosphorylation
Klafki, Hans‐Wolfgang , Huebinger, Gabi, LeCorre, Sylvie, Roder, Hanno M.

Mayo Clinic

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_9 | Pages: No page available

10.1016/j.jalz.2006.05.895 Get It

P2–049: Effect of proteasomal inhibitors on tau truncation and aggregation in a cellular model of tauopathy
Ko, Li‐wen, Fields, Tania Gendron, Yen, Shu‐Hui, Hamano, Tadanori

Mayo Clinic

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_8 | Pages: No page available

10.1016/j.jalz.2006.05.886 Get It